Click Here to return To Results

 

Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis Neurol 48:817-821, Schwid,S.R.,et al, 1997 See this aricle in Pubmed Article Abstract 4AP SR improved motor function in MS patients.The quantitative outcomes used in this study permit more sensitive evaluation of the therapeutic effect and promise to be useful in future trials of symptomatic treatments for MS.

Related Tags

(click to filter results - removes previous filter) aminopyridine,4 multiple sclerosis multiple sclerosis,treatment of treatment of neurologic disorder

Click Here to return To Results